SECOND-SET REJECTION OF MOUSE LIVER ALLOGRAFTS IS DEPENDENT ON RADIATION-SENSITIVE NONPARENCHYMAL CELLS OF GRAFT BONE MARROW ORIGIN1

Publisher Website
Google Scholar
Abstract
Livers are accepted spontaneously when transplanted orthotopically from B10 (H2b) or BALB/c (H2d) to C3H (H2k) mice without host immunosuppression. Presensitization to donor can, however, be induced by skin grafting two weeks prior to liver transplantation, resulting in second-set or "accelerated" liver graft rejection, within 4-5 days. In this study, the role of liver nonparenchymal cells (NPC) in second-set rejection was tested by donor whole-body irradiation and replacement of donor B10 liver NPC with those of either third-party (BALB/c) or recipient strain (C3H) bone marrow. Irradiation alone (9.5 Gy) of normal B10 donors before liver transplantation significantly prolonged graft survival in presensitized C3H recipients. Three months after bone marrow transplantation (BMT), chimeric livers expressing third-party or recipient haplotype, were transplanted orthotopically into unmodified C3H recipients. Graft survival was prolonged significantly compared with livers from normal or syngeneically reconstituted B10 donors. Prolonged survival of chimeric (BALB/c->B10) livers was also evident in C3H mice presensitized to alloantigens expressed on both the liver parenchymal (B10) and third-party NPC (BALB/c) by simultaneous grafting of skin from each donor strain. Determination of graft cytokine mRNA profiles 4 days posttransplant showed that replacement of donor with third-party or recipient strain BM-derived cells was associated with reduced expression of IL-2 and IFN-gamma mRNA compared with that in grafts from syngeneically reconstituted donors. IL-10 transcripts, however, were not significantly affected. The results are consistent with a key role of radiation-sensitive, donor-specific NPC of bone marrow origin in second-set liver rejection in presensitized hosts. In this process, competent donor-strain NPC appear to augment the activity of primed T cells responsible for the second-set rejection.